LNSR LENSAR posts mixed Q4 2025 results as yearoveryear revenue growth offsets steep earnings miss stock edges modestly higher DMAAR AmericanDrug management lays out domestic pharmaceutical manufacturing growth priorities in latest quarterly earnings update What Liberty FWONA is doing that smart investors recognize In Focus 20260511 American Tower Corporation AMT Valuation Reassessment Following Mizuho Upgrade Tied to CoreSite Growth and 5G Leasing Tailwinds